Conference Proceedings

THE COST-EFFECTIVENESS OF A TELAPREVIR-INCLUSIVE REGIMEN AS INITIAL THERAPY FOR GENOTYPE 1 HEPATITIS C INFECTION IN INDIVIDUALS WITH THE CC IL-28B POLYMORPHISM

Ziad F Gellad, Susanna Naggie, Shelby D Reed, Paul J Clark, Alex J Thompson, Kevin A Schulman, Andrew J Muir

HEPATOLOGY | WILEY-BLACKWELL | Published : 2011